Holen Sie sich die Stockscreener-App
27.79
0.55%
0.08
Schlusskurs vom Vortag:
$27.71
Offen:
$27.34
24-Stunden-Volumen:
452.08K
Relative Volume:
0.36
Marktkapitalisierung:
$1.89B
Einnahmen:
$2.74B
Nettoeinkommen (Verlust:
$-441.40M
KGV:
-4.2492
EPS:
-6.54
Netto-Cashflow:
$13.00M
1W Leistung:
-1.16%
1M Leistung:
-7.06%
6M Leistung:
-4.31%
1J Leistung:
-28.72%
1-Tages-Spanne:
$26.79
$27.98
1-Wochen-Bereich:
$26.17
$28.63
52-Wochen-Spanne:
$22.05
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Vergleichen Sie QDEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
27.80 | 1.88B | 2.74B | -441.40M | 13.00M | -6.54 |
|
ABT
Abbott Laboratories
|
125.48 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.58 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
360.81 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.03 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.30 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
QuidelOrtho (QDEL): Assessing Valuation After FDA Clearance for High-Sensitivity Troponin I Assay - simplywall.st
US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay - Pharmabiz.com
How to build a dashboard for QuidelOrtho Corporation stock2025 Key Lessons & Free Accurate Trade Setup Notifications - newser.com
Can QuidelOrtho Corporation stock deliver surprise earnings beatMarket Activity Recap & Risk Managed Trade Strategies - newser.com
Is QuidelOrtho Corporation trending in predictive chart modelsEarnings Recap Report & Fast Entry Momentum Alerts - newser.com
Will QuidelOrtho Corporation benefit from macro trendsJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-11-04 00:39:36 - newser.com
QuidelOrtho receives FDA clearance for high-sensitivity troponin test By Investing.com - Investing.com India
What candlestick patterns are forming on QuidelOrtho Corporation2025 Technical Patterns & Free Community Consensus Stock Picks - newser.com
QuidelOrtho (QDEL) Q3 Earnings: What To Expect - Yahoo! Finance Australia
QuidelOrtho Gets FDA Clearance for Cardiac Assay - MarketScreener
QuidelOrtho Corporation’s volatility index tracking explainedRate Cut & High Win Rate Trade Tips - newser.com
Will QuidelOrtho Corporation stock reach Wall Street targetsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Predicting QuidelOrtho Corporation trend using moving averages2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Is QuidelOrtho Corporation stock near bottom after declineWeekly Trade Analysis & Fast Gaining Stock Reports - newser.com
Quidelortho receives FDA 510(k) clearance for VITROS Immunodiagnostic Products hs Troponin I assay - MarketScreener
Analyzing recovery setups for QuidelOrtho Corporation investorsJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Will QuidelOrtho Corporation stock split attract more investorsJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Real time scanner hits for QuidelOrtho Corporation explainedWeekly Trend Recap & Long-Term Safe Investment Plans - newser.com
QuidelOrtho receives FDA clearance for high-sensitivity troponin test - Investing.com
What technical models suggest about QuidelOrtho Corporation’s comebackOptions Play & Weekly Return Optimization Plans - newser.com
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay - PR Newswire
Published on: 2025-11-03 04:51:46 - newser.com
Why QuidelOrtho Corporation stock remains on watchlists2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
Analyzing drawdowns of QuidelOrtho Corporation with statistical toolsPortfolio Performance Report & Technical Pattern Based Signals - newser.com
Volume spikes in QuidelOrtho Corporation stock – what they mean2025 Fundamental Recap & AI Driven Stock Reports - newser.com
Is QuidelOrtho Corporation (QL1A) stock a momentum leaderStop Loss & Weekly Top Stock Performers List - newser.com
Will QuidelOrtho Corporation stock benefit from infrastructure spendingQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
QuidelOrtho Faces Critical Earnings Test Amid Diverging Analyst Views - AD HOC NEWS
Will QuidelOrtho Corporation stock recover faster than marketPrice Action & Daily Stock Momentum Reports - newser.com
Is QuidelOrtho Corporation (QL1A) stock undervalued at current price2025 Retail Activity & Real-Time Volume Triggers - newser.com
Regression analysis insights on QuidelOrtho Corporation performanceEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Published on: 2025-11-02 01:25:49 - newser.com
How hedge fund analytics apply to QuidelOrtho Corporation stock2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Brighton Jones LLC Makes New $384,000 Investment in QuidelOrtho Corporation $QDEL - MarketBeat
Is QuidelOrtho Corporation (QL1A) stock testing key supportEarnings Summary Report & Risk Managed Investment Signals - newser.com
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):